* Apply Mobile APP Intervention ( iCKD APP) to current chronic kidney disease care program. * Conduct a randomized clinical trial to evaluate the clinical effectiveness of this mobile device on health behavior improvement in chronic kidney disease patients.
A mHealth app (iCKD APP) was designed to assist CKD patients to monitor their home bio-information data. Patients will be randomly assigned into the iCKD APP group(intervention) and traditional care group (control). Participants will be randomized into an 1:1 manner (intervention : control). Random assignment occurred after the consent and initial enrollment interview. Individuals randomized to the iCKD APP will provide with the equipment after randomization. Participants will follow for at least 6 months before the exit interview.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
101
Use iCKD APP to upload home bio-information data
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan
Compare clinics and home blood pressure
Systolic and diastolic blood pressure levels measured at both clinics and home will be compared between and within groups at various time points in study period.
Time frame: 3 months
Achievement of Blood pressure control target
Achievement of Blood pressure control target will be compared between and within groups at various time points in study period.
Time frame: 3 months
The monitor rate of Home Blood pressure
The monitor rate of Blood pressure at home will be compared between and within groups at various time points in study period.
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.